Bravecto Quantum vs. Bravecto Chews: Cost, Tick Coverage & Seizure Warning

Last updated: September 17, 2026 · Reading time: approx. 15 minutes

Bravecto Quantum vs. Bravecto Chews: Cost, Tick Coverage & Seizure Warning

Eylül Karaman

Dog health research · Checked against the current FDA/DailyMed Bravecto Quantum label, FDA approval records, current Bravecto Chews labeling and dated U.S. veterinary/retail prices. General education only.

Bravecto Quantum and standard Bravecto Chews contain the same active ingredient, fluralaner, but they are not interchangeable dosing experiences. Quantum is an extended-release injection with very long systemic exposure; standard Chews are redosed every 12 weeks. Both are isoxazolines and both carry neurologic precautions. The useful comparison is therefore not “new injection good vs old chew bad” — it is label coverage, treatment interval, medical history, convenience, long-exposure tradeoffs and the real all-in price at your clinic.

What changed in the Quantum label in 2026?

FDA's public approval database lists a supplemental approval dated March 16, 2026 adding Haemaphysalis longicornis (Asian longhorned tick) and Amblyomma maculatum (Gulf Coast tick) for 12-month treatment and control. Merck publicly announced the expanded label on March 18.

The current label therefore lists 12-month treatment/control for black-legged, American dog, brown dog, Asian longhorned and Gulf Coast ticks. Lone star tick control remains shorter: 8 months.

One major correction: Bravecto Chews already cover Asian longhorned ticks

The old version described Asian longhorned tick coverage as a new Quantum-only advantage. That is wrong. FDA approved Asian longhorned tick control for standard Bravecto Chews in January 2023, with 12 weeks of labeled activity.

So the current label-level comparison is:

The FDA neurologic warning: what it actually means

FDA considers isoxazoline flea-and-tick products safe and effective for the majority of animals, but the class has been associated with muscle tremors, ataxia and seizures. FDA also notes that seizures may occur in animals without a prior history.

The current Quantum label therefore says to use with caution in dogs with a history of seizures or neurologic disorders. Standard Bravecto Chews carry the same class precaution.

What does “2 of 225 dogs had seizures” tell us?

In the 455-day U.S. field study, 225 dogs received Quantum and 96 dogs received an oral active control. Two Quantum-treated dogs experienced seizures, so the label table reports seizures in 0.9% of treated dogs versus 0% in the active-control group.

But the details matter. One of those two dogs had a documented seizure within three months before the study began. That dog had six seizures over nine months starting 23 days after dosing. The second dog had eight seizures beginning 57 days after injection and was removed from the study on Day 84 for anticonvulsant management.

The real long-exposure issue with Quantum

The old article repeatedly said the drug “cannot be stopped and will release for exactly 12 months.” That wording was too simplistic. What the label actually gives us is stronger and more precise pharmacokinetic information:

• After one 15 mg/kg subcutaneous dose, the mean fluralaner half-life was about 130 days.
• Systemic fluralaner concentrations remained measurable through the end of the pharmacokinetic study on Day 450.
• The labeled parasite-control interval is not identical to the time required for the drug to disappear from plasma.

Once the injection is given, you obviously cannot “skip the next tablet” to change the current exposure. That makes adverse-event planning different from a repeatedly dosed oral product.

Quantum adverse reactions in the U.S. field study

The label also reports a hypersensitivity reaction in one treated dog after the first dose, and foreign post-approval reports include GI, injection-site, immune-mediated and neurologic events. Spontaneous post-market reports can identify safety signals but do not provide clean incidence rates.

Who should have a more detailed neurologic discussion before Quantum?

The label itself gives the core rule: use with caution in dogs with a history of seizures or neurologic disorders. That is a caution, not an automatic contraindication and not a universal instruction to choose Chews instead.

Before an extended-release injection, tell your veterinarian about previous seizures, tremors, ataxia, collapse episodes, known neurologic disease, current medications and any prior reaction to an isoxazoline.

Pregnant, breeding or lactating dogs

The current Quantum label states that safety has not been evaluated in breeding, pregnant or lactating dogs. It also points to reproductive adverse events reported after use of Bravecto Chews in breeding females.

That is more accurate than saying Quantum is categorically forbidden or proven unsafe in every breeding animal. This population simply needs label-aware veterinary decision-making.

Cost: there is no trustworthy $159 national average

Quantum is clinic-administered, weight-based and practices set their own client pricing. Public 2026 U.S. clinic lists demonstrate how wide the spread can be:

Ask your own clinic for the all-in price for your dog's current weight and whether the exam, administration or other required services are separate.

What do the standard Chews cost right now?

As a dated retail snapshot, Chewy currently lists single standard 12-week Bravecto Chews at about $79.99–$84.99 depending on weight.

One common mistake is multiplying by four and calling that a full year. Four 12-week doses cover only 48 weeks. For continuous long-run coverage, 365 ÷ 84 days is about 4.35 chews per year on an annualized basis. At the current Chewy snapshot, that is roughly $348–$369 per year in drug cost before future price changes, promotions or veterinary fees.

Quantum vs Chews: the practical tradeoffs

What to ask before choosing

• Which tick species are relevant where my dog actually lives and travels?
• If lone star ticks are a concern, should Quantum be scheduled every 8 months rather than 12?
• Does my dog have any seizure, tremor, ataxia or other neurologic history that changes the risk-benefit discussion?
• How did my dog tolerate previous fluralaner or other isoxazolines?
• What is the all-in Quantum price for my dog's weight?
• What would one year of continuous Chew coverage cost at the price I actually pay?
• What signs after treatment should trigger an urgent call?
• How should a suspected adverse event be reported to Merck/FDA?

Current label check — September 17, 2026

Frequently asked questions

Bottom line

Bravecto Quantum offers a genuinely different convenience model: very long flea/tick coverage from one veterinarian-administered injection. Its 2026 label also adds Gulf Coast tick coverage and extends Asian longhorned tick coverage to 12 months.

But the strongest comparison is not built from fear or marketing. Quantum does not cause seizures in a proven 0.9% of dogs; Chews are not instantly reversible; Asian longhorned tick coverage is not Quantum-only; and “once yearly” does not apply when lone star tick exposure requires an 8-month interval.

Use the current label, your dog's neurologic history, the tick species that matter locally, your real adherence pattern and your own clinic's price to make the decision with your veterinarian.